Can the immune system be harnessed to repair the CNS?
- 1 June 2008
- journal article
- review article
- Published by Springer Nature in Nature Reviews Neuroscience
- Vol. 9 (6), 481-493
- https://doi.org/10.1038/nrn2398
Abstract
Experimental and clinical data have demonstrated that activating the immune system in the CNS can be destructive. However, other studies have shown that enhancing an immune response can be therapeutic, and several clinical trials have been initiated with the aim of boosting immune responses in the CNS of individuals with spinal cord injury, multiple sclerosis and Alzheimer's disease. Here, we evaluate the controversies in the field and discuss the remaining scientific challenges that are associated with enhancing immune function in the CNS to treat neurological diseases.Keywords
This publication has 289 references indexed in Scilit:
- A nasal proteosome adjuvant activates microglia and prevents amyloid depositionAnnals of Neurology, 2008
- Molecular basis for passive immunotherapy of Alzheimer's diseaseProceedings of the National Academy of Sciences, 2007
- Multiple sclerosis: a complicated picture of autoimmunityNature Immunology, 2007
- UDP acting at P2Y6 receptors is a mediator of microglial phagocytosisNature, 2007
- T- and B-Cell-Deficient Mice with Experimental Stroke have Reduced Lesion Size and InflammationJournal of Cerebral Blood Flow & Metabolism, 2007
- Synergy between immune cells and adult neural stem/progenitor cells promotes functional recovery from spinal cord injuryProceedings of the National Academy of Sciences, 2006
- Glatiramer acetate fights against Alzheimer’s disease by inducing dendritic-like microglia expressing insulin-like growth factor 1Proceedings of the National Academy of Sciences, 2006
- Alternative activation of macrophagesNature Reviews Immunology, 2003
- Inflammation and cancerNature, 2002
- Points of control in inflammationNature, 2002